PBYI FY 2011 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$300M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$281,096

Gross Profit

-$281,096100.0% margin

Operating Income

-$10M3613.2% margin

Net Income

-$10M3640.3% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$55M

Total Liabilities

$1M

Stockholders' Equity

$54M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$281,096	$0	—
Gross Profit	-$281,096	$0	—
Operating Income	-$10M	-$15,976	-63474.5%
Net Income	-$10M	-$15,976	-63951.6%